Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Therapeutic BCG Vaccines Market Valued at Present and by 2029?

In recent times, the bcg vaccines market has seen consistent growth in its therapeutic sector. Projected growth reveals an increase from $56.47 billion in 2024 to $59.09 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.6%. The escalated growth during the historical period is linked to government-driven TB control initiatives, immune system modulation, worldwide immunization programs, bladder cancer treatment strategies, investments funneled into vaccine production, and the rise of drug-resistant TB strains.

In the coming years, there is an anticipation of robust growth in the therapeutic bcg vaccines market. The market is projected to expand to $75.46 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.3%. The expansion during the forecast period can be linked to the application to other indications, enhanced research in immunotherapy, worldwide initiatives against emerging infectious diseases, government backing for vaccine creation, and emphasis on eradicating tuberculosis. The forecast period is also expected to see major trends such as improvements in vaccine technology, optimization of supply chains, market mergers and collaborations, enhancing patient knowledge and awareness, alternative methods of delivery, and approaches to personalized medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9178&type=smp

#What Drivers Are Influencing Growth In The Therapeutic BCG Vaccines Market?

The global increase in tuberculosis (TB) cases is catalyzing the expansion of the therapeutic BCG vaccine market. TB is a potentially lethal infectious disease predominantly affecting the lungs. Transmission occurs when an infected individual expels tiny bacteria particles into the air through coughing or sneezing. BCG vaccines, while not capable of causing TB due to the weakness of the germs, are employed to bolster the immune system’s defense against infection. The vaccines prove consistently effective against perilous variants of TB, including adolescent TB meningitis. The ability of the BCG vaccine to combat TB infection has led to an augmentation in the utilization of therapeutic BCG vaccines. To illustrate, a UK Health Security Agency report from February 2024 revealed a 10.7% surge in TB cases in England in 2023, with 4,850 cases reported compared to the 4,380 in the previous year. Thus, the global escalation in TB cases is fostering the therapeutic BCG vaccine market’s growth.

What Are The Main Segments Identified In The Therapeutic BCG Vaccines Market Research?

The therapeutic bcg vaccines market covered in this report is segmented –

1) By Type: Therapy BCG, Immune BCG

2) By Demographics: Pediatrics, Adults

3) By End Use: Hospitals, Clinics, Other End Users

Subsegments:

1) By Therapy BCG: Intravesical BCG, Injectable BCG

2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment

What Are The Leading Trends And Opportunities In The Therapeutic BCG Vaccines Sector?

The rising prominence of strategic alliances is a significant trend observed in the therapeutic BCG vaccine market. The primary focus of prominent companies in this market is to maintain their market standing by establishing collaborations with other major players. To illustrate, ImmunityBio, an American biotech firm, formed a partnership with the Serum Institute of India, a biotech and biopharmaceutical company based in India, in May 2024. This aimed to ensure steady supply of the Bacillus Calmette-Guerin (BCG) vaccine for all types of cancer. The collaboration concentrates on producing the standard BCG (sBCG) sanctioned for usage outside America and a next-generation recombinant BCG (iBCG) that’s currently under examination. The iBCG is proposed for use in conjunction with ImmunityBio’s ANKTIVA (nogapendekin alfa inbakicept-PMLN) for approved and potential future regulations, subject to regulatory approvals.

Which Companies Play A Key Role In The Development Of The Therapeutic BCG Vaccines Market?

Major companies operating in the therapeutic bcg vaccines market include Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Cipla Limited, Instituto Butantan

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

What Are The Key Regional Developments Shaping The Therapeutic BCG Vaccines Market?

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2024. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9178&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model